# EDGAR Filing Document

**Accession Number:** 0001827635
**File Stem:** 0000000000-26-003484
**Filing Date:** 2026-4
**Character Count:** 2218
**Document Hash:** 68e4dd51f98d49f3380d74306792d582
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000000000-26-003484.hdr.sgml**: 20260528

**ACCESSION NUMBER**: 0000000000-26-003484

**CONFORMED SUBMISSION TYPE**: UPLOAD

**PUBLIC DOCUMENT COUNT**: 2

**FILED AS OF DATE**: 20260407

**FILED FOR**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Veradermics, Inc
- **CENTRAL INDEX KEY:** 0001827635
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 843304423
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** UPLOAD
- **SEC FILE NUMBER:** 377-09225

**BUSINESS ADDRESS:**
- **STREET 1:** 470 JAMES STREET
- **CITY:** NEW HAVEN
- **STATE:** CT
- **ZIP:** 06513
- **BUSINESS PHONE:** 228.372.3376

**MAIL ADDRESS:**
- **STREET 1:** 470 JAMES STREET
- **CITY:** NEW HAVEN
- **STATE:** CT
- **ZIP:** 06513

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** VeraDermics, Inc
- **DATE OF NAME CHANGE:** 20201008
**PUBLIC REFERENCE ACCESSION NUMBER**: 0001628279-26-000454

## Text-Extract

```

                                                           April 7, 2026

Reid Waldman
Chief Executive Officer
Veradermics, Incorporated
470 James St.
New Haven, CT 06513

       Re: Veradermics, Incorporated
           Draft Registration Statement on Form S-1
           Submitted April 6, 2026
           CIK No. 0001827635
Dear Reid Waldman:

       This is to advise you that we have not reviewed and will not review your
registration
statement.

        Please refer to Rules 460 and 461 regarding requests for acceleration.
We remind you
that the company and its management are responsible for the accuracy and
adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action
by the staff.

       Please contact Lauren Hamill at 303-844-1008 with any questions.

                                                           Sincerely,

                                                           Division of
Corporation Finance
                                                           Office of Life
Sciences
cc:    Nicholas Roper

```

### Attached PDF Documents

**Attachment 1:** `filename1`

_No text found in this document._